Akoya Biosciences Inc (NAS:AKYA)
$ 3.1686 -0.0514 (-1.6%) Market Cap: 156.84 Mil Enterprise Value: 199.75 Mil PE Ratio: 0 PB Ratio: 7.04 GF Score: 46/100

Akoya Biosciences Inc at UBS Global Life Science Conference (Virtual) Transcript

May 23, 2022 / 11:45AM GMT
Release Date Price: $10.36 (+4.12%)
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate

Great. Well, good morning, and welcome to the UBS Global Healthcare Conference. Kicking things off here with Akoya Biosciences, very excited to be hosting them. We have CEO, Brian McKelligon; Joe Driscoll, CFO; and Niro Ramachandran, Chief Business Officer. Sorry for butchering that there. But yes, it's great. So you know it's fireside chat format. Any questions in the audience, feel free to ask. We have the iPads up here.

Questions & Answers

John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate

So just maybe to get things started, how would you think about the growth of spatial biology as an industry? And do you think the growth of the market is really tied to NGS adoption? Or kind of how do you think about just the overall market profile?

Brian McKelligon
Akoya Biosciences, Inc. - President, CEO & Director

Well, first, John, on behalf of my colleagues and my team in Akoya,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot